Integral Ad Science Holding Corp. (NASDAQ:IAS) Shares Acquired by Charles Schwab Investment Management Inc.

Charles Schwab Investment Management Inc. increased its holdings in shares of Integral Ad Science Holding Corp. (NASDAQ:IAS) by 1.3% during the fourth quarter, HoldingsChannel.com reports. The fund owned 603,848 shares of the company’s stock after buying an additional 7,941 shares during the period. Charles Schwab Investment Management Inc.’s holdings in Integral Ad Science were worth $6,304,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of IAS. JPMorgan Chase & Co. increased its stake in shares of Integral Ad Science by 47.6% in the 3rd quarter. JPMorgan Chase & Co. now owns 717,528 shares of the company’s stock worth $7,756,000 after acquiring an additional 231,271 shares during the last quarter. Invenomic Capital Management LP increased its position in Integral Ad Science by 57.4% during the third quarter. Invenomic Capital Management LP now owns 585,309 shares of the company’s stock worth $6,327,000 after purchasing an additional 213,488 shares during the last quarter. Washington Harbour Partners LP purchased a new position in Integral Ad Science during the third quarter worth about $1,744,000. Repertoire Partners LP purchased a new position in Integral Ad Science during the third quarter worth about $1,676,000. Finally, Rice Hall James & Associates LLC boosted its holdings in Integral Ad Science by 89.2% in the 4th quarter. Rice Hall James & Associates LLC now owns 314,129 shares of the company’s stock valued at $3,280,000 after purchasing an additional 148,082 shares during the last quarter. Hedge funds and other institutional investors own 95.78% of the company’s stock.

Insider Activity

In other Integral Ad Science news, CEO Lisa Utzschneider sold 12,448 shares of the business’s stock in a transaction on Tuesday, February 4th. The stock was sold at an average price of $10.61, for a total value of $132,073.28. Following the completion of the transaction, the chief executive officer now directly owns 278,650 shares in the company, valued at approximately $2,956,476.50. The trade was a 4.28 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders have sold 19,109 shares of company stock worth $197,696 over the last ninety days. 2.00% of the stock is currently owned by insiders.

Integral Ad Science Trading Up 2.2 %

NASDAQ:IAS opened at $9.10 on Tuesday. The stock has a market capitalization of $1.49 billion, a price-to-earnings ratio of 45.50, a PEG ratio of 1.06 and a beta of 1.45. Integral Ad Science Holding Corp. has a 1 year low of $7.98 and a 1 year high of $13.62. The stock has a fifty day moving average price of $10.11 and a two-hundred day moving average price of $10.61. The company has a debt-to-equity ratio of 0.07, a quick ratio of 3.71 and a current ratio of 3.71.

Integral Ad Science (NASDAQ:IAS) last released its quarterly earnings data on Friday, February 28th. The company reported $0.09 earnings per share for the quarter, missing the consensus estimate of $0.12 by ($0.03). Integral Ad Science had a net margin of 6.39% and a return on equity of 3.47%. The firm had revenue of $153.00 million during the quarter, compared to analysts’ expectations of $148.83 million. During the same period in the previous year, the business earned $0.06 earnings per share. The business’s revenue for the quarter was up 13.9% on a year-over-year basis. As a group, sell-side analysts anticipate that Integral Ad Science Holding Corp. will post 0.26 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several research firms have recently commented on IAS. Scotiabank started coverage on shares of Integral Ad Science in a research report on Friday, February 28th. They set a “sector perform” rating and a $12.00 price target on the stock. Benchmark reaffirmed a “hold” rating on shares of Integral Ad Science in a research report on Friday, February 28th. Oppenheimer reissued an “outperform” rating on shares of Integral Ad Science in a research note on Friday, February 28th. Truist Financial raised their price objective on shares of Integral Ad Science from $16.00 to $17.00 and gave the company a “buy” rating in a report on Monday, March 3rd. Finally, Morgan Stanley restated a “mixed” rating on shares of Integral Ad Science in a research note on Monday, March 3rd. Three analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to MarketBeat, Integral Ad Science currently has an average rating of “Moderate Buy” and a consensus target price of $15.06.

About Integral Ad Science

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.